Suchergebnisse - "Cao, Xin-Xin"

PubPharm (8)

1

Phase 2 study using low dose cytarabine for adult patients with newly diagnosed Langerhans cell histiocytosis

enthalten in: Leukemia | 2024

von Chang, L. | Lang, M. | Lin, H. | +4

2

A phase 2 prospective study of bortezomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed iMCD

enthalten in: Blood | 2023

von Zhao, H. | Zhang, M. | Shen, K. | +6

3

Benefit of high-dose idarubicin as induction therapy in acute myeloid leukemia : a prospective phase 2 study

enthalten in: Annals of hematology | 2022

von Mao, Y. | Cai, H. | Shen, K. | +11

4

Phase 2 study of oral thalidomide-cyclophosphamide-dexamethasone for recurrent/refractory adult Langerhans cell histiocytosis

enthalten in: Leukemia | 2022

von Wang, J. | Liu, T. | Zhao, A. | +6

ErratumIn: Leukemia. 2023 Mar;37(3):723. - PMID 36755128

5

Cereblon expression is a prognostic marker in newly diagnosed POEMS syndrome treated with lenalidomide plus dexamethasone

enthalten in: Annals of hematology | 2021

von Cai, Q. | Gao, X. | Le, J. | +4

6

Methotrexate and cytarabine for adult patients with newly diagnosed Langerhans cell histiocytosis : A single arm, single center, prospective phase 2 study

enthalten in: American journal of hematology | 2020

von Cao, X. | Li, J. | Zhao, A. | +12

7

Phase 2 study using oral thalidomide-cyclophosphamide-prednisone for idiopathic multicentric Castleman disease

enthalten in: Blood | 2019

von Zhang, L. | Zhao, A. | Duan, M. | +7

CommentIn: Blood. 2019 Apr 18;133(16):1697-1698. - PMID 31000513

8

A prospective phase II study of low dose lenalidomide plus dexamethasone in patients with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome

enthalten in: American journal of hematology | 2018

von Li, J. | Huang, X. | Cai, Q. | +7

1
[1]